Partner Clyde Tinnen was quoted in a Reorg article, “Healthcare Mergers Dwindle Despite Increase in Sector Activity,” about an expected decline in industry deals for both health care providers and pharmaceutical companies in light of the coronavirus pandemic.
Tinnen said enforcement changes made by regulators so far in response to the spread of the coronavirus appear aimed at collaboration and conduct rather than M&A. For industry players contemplating uncertain territories, he said, “the agencies will be there to guide them on how much information can be shared without divulging prohibited competitive information such as pricing data.”
(Subscription required.)
People
Related News
July 24, 2025
In the News
Foley's Trial Team Featured Following Landmark Victory in Texas Trade Secret Case
Foley & Lardner LLP’s recent landmark appellate victory in a Texas trade secrets case is featured in the Texas Lawyer article, "Ruling Sets Precedent for Employment, Trade Secrets, Fiduciary Duty."
July 24, 2025
In the News
Gregory Husisian and David Simon on Tariff Evasion – 'Huge money at stake'
Foley & Lardner LLP partners Gregory Husisian and David Simon detailed the rise and risks of tariff evasion in the POLITICO article, "As Trump raises tariffs, companies find ways to cheat — and risk getting caught."
July 23, 2025
In the News
Aaron Maguregui on AI Scribes in Health Care – 'Technically, it's a third party listening'
Foley & Lardner LLP partner Aaron Maguregui shared insights on the growing applications for artificial intelligence across health care in the healthleaders article, “Is Your AI Scribe HIPAA-Compliant?“